Table 1

Effects of ifenprodil on the cardiovascular responses to a progressive exercise test in rats

ParametersSAPDAPMAPHRRPP
GroupsPlaceboIfenPlaceboIfenPlaceboIfenPlaceboIfenPlaceboIfen
mm Hg mm Hg mm Hg beats/min
Rest115  ± 4120  ± 595  ± 4105  ± 5102  ± 4111  ± 6424  ± 17421  ± 1749  ± 350  ± 2
Level 1 (5 cm/s)147  ± 7134  ± 6129  ± 5121  ± 8138  ± 6126  ± 8521  ± 9495  ± 2477  ± 467  ± 6
Level 2 (15 cm/s)156  ± 5138  ± 7142  ± 5122  ± 10147  ± 5128  ± 9527  ± 10501  ± 2782  ± 369  ± 6
Level 3 (25 cm/s)166  ± 4140  ± 6+ 152  ± 4122  ± 9* 157  ± 4129  ± 8* 550  ± 7506  ± 3091  ± 371  ± 5*
Level 4 (35 cm/s)172  ± 4149  ± 6* 155  ± 4121  ± 12* 160  ± 4131  ± 10* 554  ± 10534  ± 2496  ± 379  ± 4*

Placebo: rats treated with saline (n = 7); Ifen: rats treated with ifenprodil (n = 5); DAP: diastolic arterial pressure.

  • +P < .05; *P < .01: comparison between ifenprodil-treated animals and control animals at rest and at each level of the test (two-tailed unpaired Student’st test for comparisons).